Tag - pharmaceuticals

 
 

PHARMACEUTICALS

When COVID-19 first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
BUSINESS / Companies
Oct 18, 2023
Life after COVID turns rocky for reshaped health care businesses
When the coronavirus first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
Ozempic is a drug for treating Type 2 diabetes that is now being used widely as an appetite-suppressing weight loss aid.
BUSINESS / Markets
Oct 9, 2023
Ozempic threat is spurring a slump in snack and beer stocks
Snack and beverage producers are most at risk, as well as purveyors of weight-management food products such as shakes and frozen meals.
Boxes of Ozempic, a semaglutide injection drug made by Novo Nordisk
WORLD / Science & Health
Oct 6, 2023
Popular weight loss drugs linked to higher risk of certain serious gastrointestinal problems
The drug type was associated with significantly higher risks of stomach paralysis, pancreatitis and bowel obstruction.
Employees monitor the production of Covishield, the local name for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, at the Serum Institute of India in Pune, Maharashtra, India.
BUSINESS / Companies
Oct 5, 2023
Top vaccine maker seeks growth by selling shots to globetrotters
Serum Institute of India plans to start production of yellow fever and dengue shots for travelers to countries where those diseases are endemic.
A prescription injector for Ozempic, a weight loss drug
COMMENTARY / World
Oct 4, 2023
Ozempic cuts alcohol cravings. Liquor companies aren’t ready.
A survey conducted by Morgan Stanley’s AlphaWise research unit found that people consumed 62% less alcohol while taking weight loss drugs.
A nurse prepares a malaria vaccine before administering it to an infant in Kisumu, Kenya, in July 2022.
WORLD / Science & Health
Oct 3, 2023
WHO recommends malaria vaccine that will be rolled out next year
R21/Matrix-M, developed by Britain's University of Oxford, will become available by mid-2024
Demonstrators during a Women's Day march in Tokyo on March 8
JAPAN / Science & Health
Sep 28, 2023
Consent issue casts shadow on safe abortion in Japan
The law stipulates that abortion must be carried out in the early stages of pregnancy with the consent of one's spouse.
An elderly person plays a racing video game in 2022 to ward off dementia.
JAPAN / Science & Health
Sep 25, 2023
As Japan OKs Alzheimer's drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
Amgen's office in South San Francisco, California
WORLD / Science & Health
Sep 25, 2023
Big Pharma bets on AI to speed up clinical trials
AI is playing a sizeable and growing role in human drug trials.
A woman shops for medicine at a drugstore in Tokyo.
JAPAN / Science & Health
Sep 5, 2023
More young women overdosing on over-the-counter drugs
In a country where illicit drugs are hard to obtain, many have begun to abuse cough and cold medications, which are legal and easily accessible.
A health ministry panel of experts discuss their approval for an RSV vaccine during their meeting on Monday.
JAPAN / Science & Health
Aug 29, 2023
Panel OKs first RSV vaccine in Japan
People age 60 or older will be eligible to receive the vaccine.
Packages of lecanemab, marketed as Leqembi, for the U.S. market
JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Novo Nordisk' anti-obesity drug Wegovy
COMMENTARY / World
Aug 18, 2023
Insurers can’t avoid covering weight-loss drugs forever
Evidence is mounting that drugs like Wegovy not only help patients lose weight but also help prevent heart attacks and strokes.
Elizabeth Kutschke at the park with her son Ben, who was diagnosed with spinal muscular atrophy
WORLD / Science & Health
Aug 15, 2023
When a $2 million gene therapy is not enough
Ben is one of a growing number of patients with spinal muscular atrophy whose doctors are turning to additional drugs in addition to gene therapy.
As many as half of women with postpartum depression go undiagnosed.
COMMENTARY / World
Aug 9, 2023
New postpartum depression pill is a vital breakthrough
Pharma companies seem to be finally listening to the female half of the population.
More than 30 samples of drugs made by Synokem, including generic abortion pills, have failed quality tests conducted by Indian regulators and public health researchers since 2018.
BUSINESS
Aug 3, 2023
Global abortion pill provider buys from maker with poor quality record
More than 30 samples of drugs made by Delhi-based Synokem Pharmaceuticals have failed quality tests conducted by Indian regulators.
A health ministry panel has approved the messenger RNA vaccine Daichirona.
JAPAN / Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and obesity made by Novo Nordisk.
WORLD
Jul 27, 2023
U.K. probes weight-loss drug over suicidal, self-harming thoughts
Novo Nordisk said it had been notified by the government's review of potential suicidal and self-harming thoughts related to a specific class of drugs.
Japan Times
JAPAN
Jul 17, 2023
Electronic prescriptions fail to catch on in Japan
Despite the goal of countrywide integration by the end of fiscal 2024, only 2% of relevant medical facilities have begun using the system.
Japan Times
WORLD / Crime & Legal
Jul 15, 2023
The meds they bought were toxic. Now Gambian parents seek justice.
Filing a lawsuit against the Gambian government is a rare step in one of Africa's poorest countries, where few have the means to challenge authorities.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?